2. Academic Validation
  3. Structural studies on avidinorubicin, a novel anthracycline with platelet aggregation inhibitory activity

Structural studies on avidinorubicin, a novel anthracycline with platelet aggregation inhibitory activity

  • J Antibiot (Tokyo). 1991 Jun;44(6):635-45. doi: 10.7164/antibiotics.44.635.
M Aoki 1,  H Shirai,  N Nakayama,  Y Itezono,  M Mori,  T Satoh,  S Ohshima,  J Watanabe,  K Yokose,  H Seto
Affiliations

Affiliation

  • 1 Nippon Roche Research Center, Kanagawa, Japan.
PMID: 2071489 DOI: 10.7164/antibiotics.44.635
Abstract

Avidinorubicin (MW 1,214, C60H86N4O22) was isolated from the cultured broth of strain NR0576 (which was identified as Streptomyces avidinii Stapley et al.) by butyl alcohol extraction, Sephadex LH-20 column chromatography and preparative HPLC. Avidinorubicin inhibited thrombin-induced platelet aggregation with an IC50 being 7.9 microM and was determined to be a novel anthracycline possessing two units of a new aminosugar, avidinosamine, in place of two decilonitrose groups in decilorubicin.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z